Basic Ketone Engine and Booster Glucose Engine for Energy Production
Journal Title: Diabetes Research – Open Journal - Year 2016, Vol 2, Issue 1
Abstract
Recently, hyperketonemia induced by fasting or ketogenic diet calls attention because of the possibilities for various clinical applications. Animal species comparisons and biochemical data show that all fetuses can develop by using ketogenic energy through a pathway which seems to have been maintained. We hypothesized that 3-β-hydroxybutyrate (β-HB) could be the fuel for the basic engine that produces energy in all terrestrial species. However, ATP production from glucose-pyruvic acid pathway seems to be added as a dominant system in human. We hypothesize the establishment of TCA cycle in mitochondria and enough oxygen supply since two billion years ago would be the key events to promote this change. The efficacy of ATP production from β-oxidation product is 10 ATP molecules, while it is 12.5 molecules from pyruvic acid. So, evolution should select glucose burning system as a booster engine for energy production. The liver and kidney are major ketone producing organs which contain abundant glycogen particles. So, a close relationship between ketone and glucose burning system may be present. This explains why certain level of glucose is steadily maintained even in the hyperketogenic state. Ketogenic diets efficiently treat with gestational diabetes. Placenta is the ketogenic tissue which reflects high concentration of ketones in umbilical cord blood. In addition to the role of energy source, β-HB shows various pharmacological effects on disease prevention, such as cardiovascular disease, Alzheimer’s disease, epilepsy, etc. Inhibition of histone deacetylase, stimulation of FOXO, resistance to oxidative stress, protection of mitochondria, stimulation of adiponectin release, suppression of inflammasome, etc. are included. The contribution of intestinal microbiota to ketone body production should open a new field of medicine. Altogether, the above data suggest that longer-term human studies are necessary to exclude risks of unbalanced diet and to confirm the best combination of fuels for energy production, disease prevention and medical treatment.
Authors and Affiliations
Shaw Watanabe
Keywords
Related Articles
- EP ID EP550138
- DOI 10.17140/DROJ-2-125
- Views 122
- Downloads 0
NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation
Metaflammation is a metabolic inflammatory state characterized by chronic, lowgrade inflammatory response initiated by excess nutrients in metabolic cells.1 The inflammatory signaling conducted by the metabolic cell eve...
Type 1 Diabetic and Hypertensive Retinopathy: Case Presentation and Review of Literature
Background: Type 1 Diabetes (T1D) Mellitus is a complex, chronic illness that affects half a million children under the age of 15 years. Complications associated with diabetic retinopathy can be prevented with continued...
Clinical and Experimental Evidence of Hypoglycemic Neuropathy
When compared with the extensive research on hypoglycemic impacts on Central Nervous System (CNS) and cardiovascular system, the effects of hypoglycemia on the Peripheral Nervous System (PNS) have not been investigated a...
Behavioural Indicators as Risk of Diabetes Mellitus: A Community based Study in Manipur
Background: Diabetes Mellitus (DM) has become a major health issue all over the world. Lifestyle factors may affect the health of the patients with diabetes directly or indirectly. Family history of diabetes was given im...
Low Protein Brown Rice for Preventing Progression of CKD and DKD to End Stage Renal Failure
Chronic kidney disease (CKD) is pervasive into aging society, affecting permanent implications on patients’ life. Approximately 10% of the global population has CKD, and millions die each year. The prevalence of CKD was...